Therapies for Alzheimer's disease

  title={Therapies for Alzheimer's disease},
  author={Irena Melnikova},
  journal={Nature Reviews Drug Discovery},
Alzheimer’s disease (AD) is a devastating neurological disorder that affects more than 37 million people worldwide1. The economic burden of AD is massive; in the United States alone, the estimated direct and indirect annual cost of patient care is at least US$100 billion. However, the number of therapeutic options for AD remains severely limited. Currently marketed drugs for AD do not prevent or reverse this disease and are approved only for the management of symptoms. Driven by the clear unmet… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
61 Extracted Citations
4 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 61 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-4 of 4 references

prospects for rational therapeutic intervention targeting the Aβ amyloid pathway

  • C. L. Masters, Beyreuther, K. Alzheimer’s centennial legacy
  • Brain 129, 2823–2839
  • 2006

Similar Papers

Loading similar papers…